Research ArticleCancer

Vaccination during myeloid cell depletion by cancer chemotherapy fosters robust T cell responses

See allHide authors and affiliations

Science Translational Medicine  13 Apr 2016:
Vol. 8, Issue 334, pp. 334ra52
DOI: 10.1126/scitranslmed.aad8307

Log in to view full text

Log in through your institution

Log in through your institution

Stay Connected to Science Translational Medicine

Navigate This Article